T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
InnovAge Holding
INNV
$1.45B
| $41K | ﹤0.01% |
+10,922
| New | +$38.2K |
|
3002
Lucid Diagnostics
LUCD
$186M
| $41K | ﹤0.01% |
+35,136
| New | +$45.4K |
|
|
FARM
3003
DELISTED
Farmer Brothers
FARM
| $40K | ﹤0.01% |
28,843
-757
| -3% | -$1.25K |
|
|
IGMS
3004
DELISTED
IGM Biosciences
IGMS
| $40K | ﹤0.01% |
35,210
-7,654
| -18% | -$9.35K |
|
3005
Waldencast
WALD
$171M
| $40K | ﹤0.01% |
16,028
+5,855
| +58% | +$14.8K |
|
3006
BRC Inc
BRCC
$210M
| $39K | ﹤0.01% |
28,719
+5,512
| +24% | +$10.2K |
|
3007
Prairie Operating Co
PROP
$83.3M
| $38K | ﹤0.01% |
+12,524
| New | +$50.1K |
|
|
MAPS
3008
DELISTED
WM TECHNOLOGY INC A
MAPS
| $37K | ﹤0.01% |
40,560
+1,795
| +5% | +$1.93K |
|
3009
PEDEVCO
PED
$159M
| $37K | ﹤0.01% |
2,802
-73
| -3% | -$894 |
|
3010
Virgin Galactic
SPCE
$457M
| $37K | ﹤0.01% |
13,540
-10,890
| -45% | -$33.3K |
|
3011
Myomo
MYO
$59M
| $36K | ﹤0.01% |
+16,564
| New | +$60K |
|
|
AIRJW
3012
AirJoule Technologies Warrant
AIRJW
$97.5M
| $36K | ﹤0.01% |
56,154
| – | – |
|
3013
Patriot National Bancorp
PNBK
$135M
| $35K | ﹤0.01% |
+22,436
| New | +$60.6K |
|
3014
Traeger
COOK
$170M
| $33K | ﹤0.01% |
380
+151
| +66% | +$11.6K |
|
3015
PDS Biotechnology
PDSB
$13.4M
| $33K | ﹤0.01% |
24,263
-637
| -3% | -$865 |
|
3016
SKYX Platforms
SKYX
$148M
| $33K | ﹤0.01% |
+31,111
| New | +$37.5K |
|
3017
Wolfspeed
WOLF
$1.67B
| $31K | ﹤0.01% |
79,454
+25,694
| +48% | +$58.6K |
|
3018
NET Power
NPWR
$141M
| $30K | ﹤0.01% |
11,760
+1,450
| +14% | +$3.04K |
|
|
HURA
3019
TuHURA Biosciences
HURA
$158M
| $30K | ﹤0.01% |
+13,128
| New | +$44.4K |
|
3020
Beam Global
BEEM
$25.5M
| $29K | ﹤0.01% |
19,288
-312
| -2% | -$498 |
|
|
EZRA
3021
Reliance Global Group
EZRA
$1.91M
| $28K | ﹤0.01% |
374
-10
| -3% | -$533 |
|
3022
OPAL Fuels
OPAL
$68.9M
| $27K | ﹤0.01% |
+10,821
| New | +$25.1K |
|
3023
Leslie's
LESL
$6.93M
| $26K | ﹤0.01% |
3,070
-3,926
| -56% | -$51.7K |
|
3024
Dare Bioscience
DARE
$20.1M
| $25K | ﹤0.01% |
10,222
-269
| -3% | -$785 |
|
3025
Tevogen Inc. Common Stock
TVGN
$26.7M
| $24K | ﹤0.01% |
+373
| New | +$21.2K |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.